$703.21
5.160.74%
À la fermeture: -
$698.50
-4.71-0.67%
Après les heures de négociation: 7:59 PM EDT
Comments
Loading...
Orientation et prévision
Eli Lilly publie des prévisions sur le BPA et les revenus futurs, donnant aux investisseurs un aperçu du montant que la société s'attend à gagner au cours des prochaines périodes.
Get Alert | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
08/07/2025 | LLY | Eli Lilly | FY | 2025 | $21.75 | $23.00 | $21.59 | $60.00B | $62.00B | $59.45B | |
05/01/2025 | LLY | Eli Lilly | FY | 2025 | $20.78 | $22.28 | $21.59 | $58.00B | $61.00B | $59.45B | |
02/06/2025 | LLY | Eli Lilly | FY | 2025 | $22.50 | $24.00 | $21.59 | $58.00B | $61.00B | $59.45B | |
01/14/2025 | LLY | Eli Lilly | FY | 2025 | — | — | — | $58.00B | $61.00B | $59.45B | |
01/14/2025 | LLY | Eli Lilly | FY | 2024 | — | — | — | $45.00B | $45.00B | $45.16B | |
01/14/2025 | LLY | Eli Lilly | Q4 | 2024 | — | — | — | $13.50B | $13.50B | $13.57B | |
10/30/2024 | LLY | Eli Lilly | FY | 2024 | $13.02 | $13.52 | $12.66 | $45.40B | $46.00B | $45.16B | |
08/08/2024 | LLY | Eli Lilly | FY | 2024 | $16.10 | $16.60 | $12.66 | $45.40B | $46.60B | $45.16B | |
04/30/2024 | LLY | Eli Lilly and Co | FY | 2024 | $13.50 | $14.00 | $12.66 | $42.40B | $43.60B | $45.16B | |
02/06/2024 | LLY | Eli Lilly | FY | 2024 | $12.20 | $12.70 | $12.43 | $40.40B | $41.60B | $39.38B | |
11/02/2023 | LLY | Eli Lilly | FY | 2023 | $6.50 | $6.70 | $6.72 | $33.40B | $33.90B | $33.52B | |
08/08/2023 | LLY | Eli Lilly | FY | 2023 | $9.70 | $9.90 | $8.71 | $33.40B | $33.90B | $31.44B | |
04/27/2023 | LLY | Eli Lilly | FY | 2023 | $8.65 | $8.85 | $8.45 | $31.20B | $31.70B | $30.64B | |
02/02/2023 | LLY | Eli Lilly | FY | 2023 | $8.35 | $8.55 | $8.28 | $30.30B | $30.80B | $30.55B | |
01/19/2023 | LLY | Eli Lilly | FY | 2023 | $8.10 | $8.30 | $8.27 | $30.30B | $30.80B | $30.48B | |
12/13/2022 | LLY | Eli Lilly | FY | 2022 | $7.70 | $7.85 | $7.78 | $28.50B | $29.00B | $28.62B | |
12/13/2022 | LLY | Eli Lilly | FY | 2023 | $8.10 | $8.30 | $9.15 | $30.30B | $30.80B | $30.12B | |
11/01/2022 | LLY | Eli Lilly | FY | 2022 | $7.70 | $7.85 | $7.99 | $28.50B | $29.00B | $28.85B | |
08/04/2022 | LLY | Eli Lilly | FY | 2022 | $7.90 | $8.05 | $8.08 | $28.80B | $29.30B | $28.27B | |
04/28/2022 | LLY | Eli Lilly | FY | 2022 | $8.15 | $8.30 | $8.19 | $28.80B | $29.30B | $26.80B | |
02/03/2022 | LLY | Eli Lilly | FY | 2022 | $8.50 | $8.65 | $7.54 | $27.80B | $28.30B | $24.88B | |
12/15/2021 | LLY | Eli Lilly | FY | 2022 | $8.50 | $8.65 | $7.30 | $27.80B | $28.30B | $24.73B | |
12/15/2021 | LLY | Eli Lilly | FY | 2021 | $8.15 | $8.20 | $7.13 | $28.00B | $28.30B | $24.57B | |
10/26/2021 | LLY | Eli Lilly | FY | 2021 | $7.95 | $8.05 | $6.80 | $27.20B | $27.60B | $23.52B | |
08/03/2021 | LLY | Eli Lilly | FY | 2021 | $7.80 | $8.00 | $7.90 | $26.80B | $27.40B | $27.22B | |
04/27/2021 | LLY | Eli Lilly | FY | 2021 | $7.80 | $8.00 | $8.23 | $26.60B | $27.60B | $27.69B | |
01/29/2021 | LLY | Eli Lilly | FY | 2021 | $7.75 | $8.40 | $8.20 | $26.50B | $28.00B | $27.59B | |
12/15/2020 | LLY | Eli Lilly | FY | 2021 | $7.75 | $8.40 | $8.07 | $26.50B | $28.00B | $26.47B | |
12/15/2020 | LLY | Eli Lilly | FY | 2020 | $7.45 | $7.65 | $7.32 | $24.20B | $24.70B | $23.93B |
FAQ
Quelles sont les dernières directives pour Eli Lilly (LLY) ?
Les dernières prévisions pour Eli Lilly (LLY) ont été communiquées le août 7, 2025 pour l'année complète 2025. L'entreprise a fourni des prévisions de bénéfice par action dans une fourchette de $21.75 à $23.00, par rapport à un BPA estimé de $21.59. De plus, Eli Lilly a prévu un chiffre d'affaires entre $60.00B et $62.00B pour le trimestre.
Parcourir guidance et prévisions sur toutes les actions.